Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2024 from OUS - Institute for Cancer Genetics and Informatics

18 publications found

Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
J Neurooncol (in press)
DOI 10.1007/s11060-024-04709-z, PubMed 38762830

Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes LTN, Vålerhaugen H, Heim S, Micci F (2024)
NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
Front Oncol, 14, 1371980
DOI 10.3389/fonc.2024.1371980, PubMed 38571499

Cyll K, Skaaheim Haug E, Pradhan M, Vlatkovic L, Carlsen B, Löffeler S, Kildal W, Skogstad K, Hauge Torkelsen F, Syvertsen RA, Askautrud HA, Liestøl K, Kleppe A, Danielsen HE (2024)
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance
Br J Cancer (in press)
DOI 10.1038/s41416-024-02780-x, PubMed 38961192

Feroz B, Pan TL, Leitner K, Ebner C, Steger K, Kildal W, Kristensen G, Zeimet AG, Hackl H, Fiegl H, Marth C, Wieser V (2024)
Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome
Int J Gynecol Cancer (in press)
DOI 10.1136/ijgc-2023-005188, PubMed 38969503

Frei AL, McGuigan A, Sinha RRAK, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson T, Saunders MP, Oien KA, Maka N, Pezzella F, Campo L, Browne M, Glaire M, Kildal W, Danielsen HE, Hay J, Edwards J, Sansom O, Kelly C, Tomlinson I, Kerr R, Kerr D, Domingo E et al. (2024)
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
Lancet Oncol, 25 (2), 198-211
DOI 10.1016/S1470-2045(23)00560-0, PubMed 38301689

Halldorsson S, Nagymihaly RM, Patel A, Brandal P, Panagopoulos I, Leske H, Lund-Iversen M, Sahm F, Vik-Mo EO (2024)
Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing
Neuropathol Appl Neurobiol, 50 (3), e12984
DOI 10.1111/nan.12984, PubMed 38783575

Hatchett WJ, Brunetti M, Andersen K, Tandsæther MR, Lobmaier I, Lund-Iversen M, Lien-Dahl T, Micci F, Panagopoulos I (2024)
Genetic characterization of intramuscular myxomas
Pathol Oncol Res, 30, 1611553
DOI 10.3389/pore.2024.1611553, PubMed 38317844

Kenseth A, Kantorova D, Seo MK, Aas E, Cairns J, Kerr D, Askautrud H, Jacobsen JE (2024)
Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?
Pharmacoeconomics, 42 (6), 679-691
DOI 10.1007/s40273-024-01371-1, PubMed 38584239

Korkmaz A, Bernhardsen GP, Cirit B, Koprucu Suzer G, Kayan H, Biçmen H, Tahra M, Suner A, Lehto SM, Sag D, Saatcioglu F (2024)
Sudarshan Kriya Yoga Breathing and a Meditation Program for Burnout Among Physicians: A Randomized Clinical Trial
JAMA Netw Open, 7 (1), e2353978
DOI 10.1001/jamanetworkopen.2023.53978, PubMed 38294813

Lindemann K, Kildal W, Kleppe A, Tobin KAR, Pradhan M, Isaksen MX, Vlatkovic L, Danielsen HE, Kristensen GB, Askautrud HA (2024)
Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer
Eur J Cancer, 200, 113584
DOI 10.1016/j.ejca.2024.113584, PubMed 38330767

Panagopoulos I, Andersen K, Gorunova L, Lobmaier I (2024)
Fusion of Platelet Derived Growth Factor Receptor Alpha (PDGFRA) With Ubiquitin Specific Peptidase 8 (USP8) in a Calcified Chondroid Mesenchymal Neoplasm Harboring t(4;15)(q12;q21) as a Sole Aberration
Cancer Genomics Proteomics, 21 (3), 252-259
DOI 10.21873/cgp.20444, PubMed 38670591

Panagopoulos I, Andersen K, Johannsdottir IMR, Tandsæther MR, Micci F, Heim S (2024)
Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL)
Cancer Genomics Proteomics, 21 (1), 1-11
DOI 10.21873/cgp.20424, PubMed 38151288

Panagopoulos I, Andersen K, Stavseth V, Torkildsen S, Heim S, Tandsæther MR (2024)
Germline MYOF1::WNK4 and VPS25::MYOF1 Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome
Cancer Genomics Proteomics, 21 (3), 272-284
DOI 10.21873/cgp.20446, PubMed 38670586

Panagopoulos I, Andersen K, Wik HS, Tandsæther MR (2024)
Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome
Anticancer Res, 44 (4), 1389-1397
DOI 10.21873/anticanres.16935, PubMed 38537997

Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T (2024)
Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
Acta Oncol, 63, 83-94
DOI 10.2340/1651-226X.2024.24970, PubMed 38501768

Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Neuro Oncol, 26 (7), 1302-1309
DOI 10.1093/neuonc/noae037, PubMed 38452246

Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
Acta Neuropathol Commun, 12 (1), 55
DOI 10.1186/s40478-023-01695-7, PubMed 38581034

Zhang T, Zhao F, Lin Y, Liu M, Zhou H, Cui F, Jin Y, Chen L, Sheng X (2024)
Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression
Theranostics, 14 (3), 1065-1080
DOI 10.7150/thno.92336, PubMed 38250042

0.13s